Vanberra Signal

Atantares

Curated by Signal

Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies

Overview

Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies. The company has developed a coagulation device that helps in monitoring specific drugs or blood products. It uses coagulation assays that monitor platelet function tests, clotting times, and viscoelasticity with a proprietary biochip platform. It provides a chimeric antigen receptor that helps in the treatment of hematological tumors, cardiac diseases, neurological disorders, and cancer. It uses an ultrasensitive immunoassay platform that provides cytokine profile data for managing CAR T-cell therapy and CRS mitigation.

Key facts

Founded
2020

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of a medical device for central nervous therapy

    Life Sciences TechnologyAtlanta, United States
  • Imaging supplies and accessories for radiology suites

    Life Sciences TechnologyCaledonia, United States
  • Monitoring devices for home-use

    Life Sciences TechnologyStafford, United States

About Atantares

What does Atantares do?

Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies.

Where is Atantares headquartered?

Atantares is headquartered in Cambridge, United States.

When was Atantares founded?

Atantares was founded in 2020.

Which sector is Atantares in?

Atantares operates in Life Sciences Technology.

Who are Atantares's competitors?

Companies similar to Atantares include Medical Edge Solutions, Cone Instruments, and Innovo Medical.